An update on PET-based molecular imaging in neuro-oncology: challenges and implementation for a precision medicine approach in cancer care
Publication in refereed journal

香港中文大學研究人員
替代計量分析
.

其它資訊
摘要PET imaging using novel radiotracers show promises for tumor grading and molecular characterization through visualizing molecular and functional properties of the tumors. Application of PET tracers in brain neoplasm depends on both type of the neoplasm and the research or clinical significance required to be addressed. In clinical neuro-oncology, 18F-FDG is used mainly to differentiate tumor recurrence from radiation-induced necrosis, and novel PET agents show attractive imaging properties. Novel PET tracers can offer biologic information not visible via contrast-enhanced MRI or 18F-FDG PET. This review aims to provide an update on the complementary role of PET imaging in neuro-oncology both in research and clinical settings along with presenting interesting cases in this context.
出版社接受日期19.08.2019
著者Hossein Shooli, Habibollah Dadgar, Yì-Xiáng J Wang, Manochehr Seyedi Vafaee, Saman Rassaei Kashuk, Reza Nemati, Esmail Jafari, Iraj Nabipour, Ali Gholamrezanezhad, Majid Assadi, Mykol Larvie
期刊名稱QUANTITATIVE IMAGING IN MEDICINE AND SURGERY
出版年份2019
月份9
卷號9
期次9
頁次1597 - 1610
國際標準期刊號2223-4292
電子國際標準期刊號2223-4306
語言美式英語
關鍵詞Positron emission tomography (PET), brain tumors, magnetic resonance imaging (MRI), precision medicine, molecular imaging, 68Ga-DOTA-peptide, 68Ga-labeled PSMA

上次更新時間 2020-23-11 於 23:44